These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 3119552

  • 1. Comparative in-vitro activity of Ro 23-6240, a new trifluorinated quinolone.
    Verbist L.
    J Antimicrob Chemother; 1987 Sep; 20(3):363-72. PubMed ID: 3119552
    [Abstract] [Full Text] [Related]

  • 2. Comparative in vitro activities of pefloxacin, ofloxacin, enoxacin and ciprofloxacin against 256 clinical isolates.
    Arpi M, Gahrn-Hansen B, Søgaard P, Bentzon MW.
    Acta Pathol Microbiol Immunol Scand B; 1987 Apr; 95(2):141-6. PubMed ID: 3473910
    [Abstract] [Full Text] [Related]

  • 3. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
    King A, Phillips I.
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100
    [Abstract] [Full Text] [Related]

  • 4. [Comparative in vitro activity of 10 new 4-quinolones against enteropathogenic bacteria].
    Habiyaremye I, Verbist L, Vandepitte J.
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):800-4. PubMed ID: 3116489
    [Abstract] [Full Text] [Related]

  • 5. Comparative in vitro activity of RO 23-6240 (fleroxacin), a new 4-quinolone derivative.
    Machka K, Braveny I.
    Eur J Clin Microbiol; 1987 Aug; 6(4):482-5. PubMed ID: 3117538
    [Abstract] [Full Text] [Related]

  • 6. In vitro activity of RO 23-6240 (AM-833): a new fluoroquinolone.
    Fass RJ, Helsel VL.
    Diagn Microbiol Infect Dis; 1987 Apr; 6(4):293-9. PubMed ID: 3107872
    [Abstract] [Full Text] [Related]

  • 7. [In vitro activity of new quinolones against nonfermenters and references to sensitivity tests].
    Grimm H.
    Infection; 1986 Apr; 14 Suppl 3():S191-5. PubMed ID: 3093387
    [Abstract] [Full Text] [Related]

  • 8. In vitro susceptibility of aerobic gram-negative blood culture isolates to oxolinic acid, norfloxacin, ciprofloxacin, enoxacin, pefloxacin, ofloxacin and oxo-enoxacin.
    Van der Auwera P.
    Infection; 1986 Apr; 14(3):142-4. PubMed ID: 2942489
    [Abstract] [Full Text] [Related]

  • 9. In-vitro selection of bacteria resistant to the 4-quinolone agents.
    Limb DI, Dabbs DJ, Spencer RC.
    J Antimicrob Chemother; 1987 Jan; 19(1):65-71. PubMed ID: 3470281
    [Abstract] [Full Text] [Related]

  • 10. In vitro comparison of A-56619, A-56620, amifloxacin, ciprofloxacin, enoxacin, norfloxacin, and ofloxacin against methicillin-resistant Staphylococcus aureus.
    Smith SM.
    Antimicrob Agents Chemother; 1986 Feb; 29(2):325-6. PubMed ID: 2940966
    [Abstract] [Full Text] [Related]

  • 11. Antimicrobial activity evaluations of two new quinolones, PD127391 (CI-960 and AM-1091) and PD131628.
    Barrett MS, Jones RN, Erwin ME, Johnson DM, Briggs BM.
    Diagn Microbiol Infect Dis; 1991 Feb; 14(5):389-401. PubMed ID: 1665774
    [Abstract] [Full Text] [Related]

  • 12. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
    Bassey CM, Baltch AL, Smith RP.
    J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401
    [Abstract] [Full Text] [Related]

  • 13. In vitro antimicrobial activity of sparfloxacin (AT-4140, CI-978, PD 131501) compared with numerous other quinolone compounds.
    Jones RN, Barrett MS, Erwin ME, Briggs BM, Johnson DM.
    Diagn Microbiol Infect Dis; 1991 May; 14(4):319-30. PubMed ID: 1909615
    [Abstract] [Full Text] [Related]

  • 14. The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents.
    McCarter YS, Mazens-Sullivan MF, Bartlett RC.
    Chemotherapy; 1992 May; 38(5):308-18. PubMed ID: 1337507
    [Abstract] [Full Text] [Related]

  • 15. In-vitro activity of newer quinolones against aerobic bacteria.
    Auckenthaler R, Michéa-Hamzehpour M, Pechère JC.
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():29-39. PubMed ID: 2940214
    [Abstract] [Full Text] [Related]

  • 16. In-vitro activity of six fluorinated quinolones against Mycobacterium tuberculosis.
    Berlin OG, Young LS, Bruckner DA.
    J Antimicrob Chemother; 1987 May; 19(5):611-5. PubMed ID: 3112095
    [Abstract] [Full Text] [Related]

  • 17. In-vitro activity of fleroxacin compared with three other quinolones.
    Bremner DA, Dickie AS, Singh KP.
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():19-23. PubMed ID: 3144536
    [Abstract] [Full Text] [Related]

  • 18. In vitro studies of fleroxacin (Ro 23-6240), a new trifluorinated quinolone derivative.
    Digranes A, Benonisen E, Salveson A, Zahm F.
    Chemotherapy; 1988 Oct; 34(5):401-10. PubMed ID: 3141116
    [Abstract] [Full Text] [Related]

  • 19. In vitro activity of CI-934 compared with ciprofloxacin, enoxacin, norfloxacin, and vancomycin.
    Floyd-Reising SA, Kelley SG, Hindler JA, Young LS.
    Diagn Microbiol Infect Dis; 1987 Apr; 6(4):301-6. PubMed ID: 3472704
    [Abstract] [Full Text] [Related]

  • 20. The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae.
    Ridgway GL, O'Hare MD, Felmingham D, Grüneberg RN.
    Drugs Exp Clin Res; 1985 Apr; 11(4):259-62. PubMed ID: 2941258
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.